| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1045455569 |
| P356 | DOI | 10.1007/S10120-012-0182-1 |
| P698 | PubMed publication ID | 22898806 |
| P5875 | ResearchGate publication ID | 230685369 |
| P2093 | author name string | Hae Myung Jeon | |
| Eun Kyoung Jeon | |||
| Sook Hee Hong | |||
| Yu Ri Shin | |||
| Cho Hyun Park | |||
| Young Seon Hong | |||
| Sang Young Roh | |||
| Kyo Yung Song | |||
| P2860 | cites work | New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada | Q27860904 |
| Bevacizumab in combination with chemotherapy as first-line therapy in advanced gastric cancer: a randomized, double-blind, placebo-controlled phase III study | Q29620647 | ||
| Multivariate prognostic factor analysis in locally advanced and metastatic esophago-gastric cancer--pooled analysis from three multicenter, randomized, controlled trials using individual patient data | Q33203756 | ||
| Prospective randomized trial comparing mitomycin, cisplatin, and protracted venous-infusion fluorouracil (PVI 5-FU) With epirubicin, cisplatin, and PVI 5-FU in advanced esophagogastric cancer | Q33341957 | ||
| Treatment of colorectal peritoneal carcinomatosis with systemic chemotherapy: a pooled analysis of north central cancer treatment group phase III trials N9741 and N9841. | Q35721069 | ||
| Significance of vascular endothelial growth factor in growth and peritoneal dissemination of ovarian cancer | Q35954103 | ||
| Quantitative prognostic indicators of peritoneal dissemination of gastric cancer | Q36450287 | ||
| Treatment of gastric cancer with peritoneal carcinomatosis by cytoreductive surgery and HIPEC: a systematic review of survival, mortality, and morbidity | Q37895575 | ||
| Biodistribution of humanized anti-VEGF monoclonal antibody/bevacizumab on peritoneal metastatic models with subcutaneous xenograft of gastric cancer in mice | Q39759253 | ||
| Effect of bevacizumab, a humanized monoclonal antibody to vascular endothelial growth factor, on peritoneal metastasis of MNK-45P human gastric cancer in mice | Q39867148 | ||
| Safety and efficacy of bidirectional chemotherapy for treatment of patients with peritoneal dissemination from gastric cancer: Selection for cytoreductive surgery | Q43288249 | ||
| Toward curative treatment of peritoneal carcinomatosis from nonovarian origin by cytoreductive surgery combined with perioperative intraperitoneal chemotherapy: a multi-institutional study of 1,290 patients | Q43421690 | ||
| Clinical efficacy of S-1 combined with cisplatin for advanced gastric cancer | Q43534629 | ||
| Outcome of palliative operations for malignant bowel obstruction in patients with peritoneal carcinomatosis from nongynecological cancer. | Q45958054 | ||
| Pharmacokinetic changes induced by the volume of chemotherapy solution in patients treated with hyperthermic intraperitoneal mitomycin C. | Q46647228 | ||
| Intraperitoneal docetaxel combined with S-1 for advanced gastric cancer with peritoneal dissemination. | Q64882369 | ||
| Intraoperative lavage for cytological examination in 1,297 patients with gastric carcinoma | Q73097148 | ||
| Results of treatment of 385 patients with peritoneal surface spread of appendiceal malignancy | Q73327577 | ||
| Peritoneal carcinomatosis from non-gynecologic malignancies: results of the EVOCAPE 1 multicentric prospective study | Q73368601 | ||
| Combination chemotherapy with capecitabine (X) and Cisplatin (P) as first line treatment in advanced gastric cancer: experience of 223 patients with prognostic factor analysis | Q79710709 | ||
| VEGF significance in peritoneal recurrence from gastric cancer | Q81019483 | ||
| P433 | issue | 3 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | peritoneal carcinomatosis | Q2071182 |
| chemotherapy | Q974135 | ||
| P304 | page(s) | 290-300 | |
| P577 | publication date | 2012-08-17 | |
| P1433 | published in | Gastric Cancer | Q15724608 |
| P1476 | title | Treatment outcomes of systemic chemotherapy for peritoneal carcinomatosis arising from gastric cancer with no measurable disease: retrospective analysis from a single center | |
| P478 | volume | 16 |
| Q89953671 | A critical analysis of the cytoreductive surgery with hyperthermic intraperitoneal chemotherapy combo in the clinical management of advanced gastric cancer: an effective multimodality approach with scope for improvement |
| Q34015030 | Aggressive locoregional surgical therapy for gastric peritoneal carcinomatosis |
| Q92504802 | Complete cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy for gastric cancer with peritoneal metastases: results of a propensity score matching analysis from France |
| Q26774538 | Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in gastric cancer |
| Q92462012 | History of Peritoneal Surface Malignancy Treatment in Japan |
| Q92447034 | Long Term Survival after Cytoreductive Surgery Combined with Perioperative Chemotherapy in Gastric Cancer Patients with Peritoneal Metastasis |
| Q92618065 | Pressurized intraperitoneal aerosol chemotherapy (PIPAC) in combination with standard of care chemotherapy in primarily untreated chemo naïve upper gi-adenocarcinomas with peritoneal seeding - a phase II/III trial of the AIO/CAOGI/ACO |
| Q92617822 | Survival outcomes after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for peritoneal carcinomatosis from gastric cancer: a systematic review |
| Q36758921 | The Role of Hyperthermic Intraperitoneal Chemotherapy in Gastric Cancer. |
Search more.